Publicaties

Hieronder staan alle publicaties die zijn voortgekomen uit BlaZIB, en de congressen en/of symposia waarop onderzoek van BlaZIB is gepresenteerd. Onderstaande lijst wordt aangevuld op het moment dat er nieuwe publicaties verschijnen of presentaties zijn gehouden.

Publicaties BlaZIB

 

Congressen/symposia

  • NKR symposium (november 2021) – Centralisatie chirurgische behandeling en postoperatieve mortaliteit bij blaaskanker, resultaten uit de BlaZIB-studiegroep
  • NKR symposium (november 2021) – The impact of the COVID-19 pandemic on bladder cancer care in the Netherlands
  • NKR symposium (november 2021) – Part of untreated patients with non-metastatic muscle invasive bladder is wrongfully denied life prolonging treatment
  • ENCR (november 2021) – The impact of the COVID-19 pandemic on bladder cancer care in the Netherlands
  • IACR (oktober 2021) – The impact of the COVID-19 pandemic on bladder cancer care in the Netherlands
  • EAU21 (juli 2021) – Very low risk of severe complications after a single, post-operative instillation of intravesical chemotherapy in patients with low- or intermediate risk urothelial carcinoma of the bladder
  • EAU21 (juli 2021) – Characteristics and survival of untreated versus treated patients with non-metastatic muscle invasive bladder cancer
  • WEON (juni 2021) – Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer
  • WEON (juni 2021) – Characteristics and survival of untreated versus treated patients with non-metastatic muscle invasive bladder cancer
  • SONCOS (februari 2021) – Stand van zaken BlaZIB, resultaten van lopende onderzoeken samengevat en work in progress
  • Global Conference on Bladder Cancer (BLADDR) (oktober 2020) – Very low risk of severe complications after a single, post-operative instillation of intravesical chemotherapy in patients with low- or intermediate risk urothelial carcinoma of the bladder